Medical News

RSS

Taro Pharmaceutical Industries to discontinue manufacturing operations in Roscrea, Ireland

Taro Pharmaceutical Industries Ltd. today announced that it will discontinue manufacturing operations at the sterile manufacturing facility of its Irish subsidiary, Taro Pharmaceuticals Ireland Limited, in Roscrea, Ireland (“Taro Ireland”).

18 Feb 2010

Gentiva Health Services announces fourth-quarter and fiscal year 2009 results

Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported fourth quarter and full year fiscal 2009 results.

18 Feb 2010

Phase 2 study results: VEGF Trap-Eye improves vision in patients with DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG announced that VEGF Trap-Eye showed positive results in a Phase 2 study in patients with diabetic macular edema (DME).

18 Feb 2010

Isotechnika Labs amends Isodiagnostika sales agreement with Paladin Labs

Isotechnika Pharma Inc. today announced that its wholly owned subsidiary, Isotechnika Labs, has amended its agreement with Paladin Labs Inc. concerning its remaining stake in the revenue stream from the Isodiagnostika business sold to Paladin on June 18, 2009. Under the agreement, Isotechnika Labs was entitled to receive a revenue stream equivalent to 88 percent of the net profits of Isodiagnostika through to June 18 2016.

18 Feb 2010

Five Star Quality Care reports total revenues of $304.8M for fourth-quarter 2009

Five Star Quality Care, Inc. today announced its financial results for the quarter and year ended December 31, 2009.

18 Feb 2010

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

West Pharmaceutical Services, Inc. today announced its results for the fourth quarter and full year of 2009.

18 Feb 2010

Antigenics announces fourth-quarter and full-year 2009 financial results

Antigenics Inc. reported today its results for the quarter and year ended December 31, 2009. The company reported net income attributable to common stockholders of $1.7 million, or $0.02 per share, basic and diluted, for the fourth quarter of 2009, compared with net income attributable to common stockholders in the fourth quarter of 2008 of $3.9 million, or $0.06 per share, basic and diluted.

18 Feb 2010

IRA to offer Personal Genetic Health and Ancestry Testing to residents of Latin America

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company today announced that the Instituto de Referencia Andino (IRA), a Clinical Laboratory and Division of Rochem Biocare will offer Personal Genetic Health and Ancestry Testing to residents of Latin America.

18 Feb 2010

Inquisit partnership enables Alsius expand educational programming and increase webinar attendance by 940%

Through a partnership with Inquisit, Amerinet’s strategic education partner, Alsius Corporation (recently acquired by ZOLL Medical Corporation) was able to expand educational programming related to its innovative products and increase attendance to its webinars by 940 percent.

18 Feb 2010

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

On the first anniversary of the American Recovery and Reinvestment Act (ARRA) - the economic stimulus - the nation's research universities today provided nearly 100 examples of how a relatively small element of the measure is paying outsize short- and long-term dividends for the nation. Of the $787 billion contained in the ARRA, $21.5 billion is allocated for research and science infrastructure.

18 Feb 2010

International Merchant Advisors announces development of new line of Wellness Centers and medical marijuana treatment centers

International Merchant Advisors, Inc. announced today that the company intends to develop a new line of Wellness Centers and medical marijuana treatment centers. CEO Mel Roseman stated, "Wellness Centers and medical marijuana are promising new treatment areas, but will require stringent systems and controls to engender the confidence of both patients and the regulatory community.

18 Feb 2010

Charity Navigator bestows MMRF coveted 4-star rating for efforts in finding cure for multiple myeloma

The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.

18 Feb 2010

Travellers are likely to become increasingly exposed to canecutter's disease: Study

A team led by PhD researcher Dr Colleen Lau from the School of Population Health http://www.sph.uq.edu.au/ , has discovered the disease, known medically as leptospirosis, was traditionally a concern for males working in the agricultural and livestock industries, as it is contracted from contact with the urine of host animals.

18 Feb 2010

Confidential Mediation Services opens new offices in San Francisco and Los Angeles

Confidential Mediation Services announces the opening of its offices in San Francisco and Los Angeles, facilitating the resolution of disputes arising within the medicinal marijuana industry. As the first and only firm in the United States specializing in conflict resolution for this industry, Confidential Mediation Services is poised to expand as marijuana enterprises enlarge, mature, and gain legitimacy.

18 Feb 2010

Dartmouth Atlas hospital ratings could be misleading, says former CMS Senior Policy Advisor

A "Perspective" piece in today's New England Journal of Medicine by Peter B. Bach, MD, MAPP, points out that policy makers are relying on hospital ratings from the Dartmouth Atlas that could be misleading.

18 Feb 2010

WellCare Health Plans reports net income of $39.9M for 2009

WellCare Health Plans, Inc. today reported results for the year and fourth quarter ended December 31, 2009. As determined under generally accepted accounting principles (“GAAP”), the Company reported net income of $39.9 million, or $0.95 per diluted share, for the year 2009, compared with a net loss of $36.8 million, or $0.89 per diluted share, for the year 2008.

18 Feb 2010

Long-term solution for U.S. medical isotope shortage needed

The medical community has taken additional steps to help alleviate ongoing challenges facing physicians and patients due to the worldwide isotope shortage. SNM cautions that while this is good news, a long-term solution for the U.S. is needed urgently.

18 Feb 2010

First Edition: February 18, 2010

Today's headlines focus on continuing hopes for health reform as well as various health industry developments.

18 Feb 2010

INC Research creates management program for strategic clinical delivery alliances with pharma and biotechnology customers

INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.

18 Feb 2010

PK/PD data demonstrates clear relationship between TBR-652 plasma concentrations and antiviral activity

Pharmacokinetic/pharmacodynamic (PK/PD) data for TBR-652, which is being developed by Tobira Therapeutics for the treatment of HIV infection, show a strong relationship between drug exposure and viral suppression with this next-generation CCR5 receptor antagonist. These data were presented here today at the 17th Conference on Retroviruses and Opportunistic Infections (CROI).

18 Feb 2010

Medical News

Taro Pharmaceutical Industries to discontinue manufacturing operations in Roscrea, Ireland

Gentiva Health Services announces fourth-quarter and fiscal year 2009 results

Phase 2 study results: VEGF Trap-Eye improves vision in patients with DME

Isotechnika Labs amends Isodiagnostika sales agreement with Paladin Labs

Five Star Quality Care reports total revenues of $304.8M for fourth-quarter 2009

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

Antigenics announces fourth-quarter and full-year 2009 financial results

IRA to offer Personal Genetic Health and Ancestry Testing to residents of Latin America

Inquisit partnership enables Alsius expand educational programming and increase webinar attendance by 940%

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

International Merchant Advisors announces development of new line of Wellness Centers and medical marijuana treatment centers

Charity Navigator bestows MMRF coveted 4-star rating for efforts in finding cure for multiple myeloma

Travellers are likely to become increasingly exposed to canecutter's disease: Study

Confidential Mediation Services opens new offices in San Francisco and Los Angeles

Dartmouth Atlas hospital ratings could be misleading, says former CMS Senior Policy Advisor

WellCare Health Plans reports net income of $39.9M for 2009

Long-term solution for U.S. medical isotope shortage needed

First Edition: February 18, 2010

INC Research creates management program for strategic clinical delivery alliances with pharma and biotechnology customers

PK/PD data demonstrates clear relationship between TBR-652 plasma concentrations and antiviral activity

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News